🇺🇸 FDA
Patent

US 8518636

Tangential flow filtration devices and methods for leukocyte enrichment

granted A61PA61P37/02

Quick answer

US patent 8518636 (Tangential flow filtration devices and methods for leukocyte enrichment) held by Northwest Biotherapeutics, Inc. expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwest Biotherapeutics, Inc.
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P37/02